218 related articles for article (PubMed ID: 25986936)
21. Ligand bias at metabotropic glutamate 1a receptors: molecular determinants that distinguish β-arrestin-mediated from G protein-mediated signaling.
Emery AC; DiRaddo JO; Miller E; Hathaway HA; Pshenichkin S; Takoudjou GR; Grajkowska E; Yasuda RP; Wolfe BB; Wroblewski JT
Mol Pharmacol; 2012 Aug; 82(2):291-301. PubMed ID: 22584219
[TBL] [Abstract][Full Text] [Related]
22. Endosomal signaling via cAMP in parathyroid hormone (PTH) type 1 receptor biology.
Peña KA; Savransky S; Lewis B
Mol Cell Endocrinol; 2024 Feb; 581():112107. PubMed ID: 37981188
[TBL] [Abstract][Full Text] [Related]
23. Modulation of PTH1R signaling by an ECD binding antibody results in inhibition of β-arrestin 2 coupling.
Sarkar K; Joedicke L; Westwood M; Burnley R; Wright M; McMillan D; Byrne B
Sci Rep; 2019 Oct; 9(1):14432. PubMed ID: 31594997
[TBL] [Abstract][Full Text] [Related]
24. Modulation of PTH1R signaling by an extracellular binding antibody.
Sarkar K; Joedicke L; Westwood M; Burnley R; Wright M; McMillan D; Byrne B
Vitam Horm; 2022; 120():109-132. PubMed ID: 35953107
[TBL] [Abstract][Full Text] [Related]
25. Fulfilling the Promise of "Biased" G Protein-Coupled Receptor Agonism.
Luttrell LM; Maudsley S; Bohn LM
Mol Pharmacol; 2015 Sep; 88(3):579-88. PubMed ID: 26134495
[TBL] [Abstract][Full Text] [Related]
26. Discovery of β-arrestin-biased dopamine D2 ligands for probing signal transduction pathways essential for antipsychotic efficacy.
Allen JA; Yost JM; Setola V; Chen X; Sassano MF; Chen M; Peterson S; Yadav PN; Huang XP; Feng B; Jensen NH; Che X; Bai X; Frye SV; Wetsel WC; Caron MG; Javitch JA; Roth BL; Jin J
Proc Natl Acad Sci U S A; 2011 Nov; 108(45):18488-93. PubMed ID: 22025698
[TBL] [Abstract][Full Text] [Related]
27. β-Arrestin Recruitment and Biased Agonism at Free Fatty Acid Receptor 1.
Mancini AD; Bertrand G; Vivot K; Carpentier É; Tremblay C; Ghislain J; Bouvier M; Poitout V
J Biol Chem; 2015 Aug; 290(34):21131-21140. PubMed ID: 26157145
[TBL] [Abstract][Full Text] [Related]
28. Loss of biased signaling at a G protein-coupled receptor in overexpressed systems.
Li A; Liu S; Huang R; Ahn S; Lefkowitz RJ
PLoS One; 2023; 18(3):e0283477. PubMed ID: 36961836
[TBL] [Abstract][Full Text] [Related]
29. Screening β-arrestin recruitment for the identification of natural ligands for orphan G-protein-coupled receptors.
Southern C; Cook JM; Neetoo-Isseljee Z; Taylor DL; Kettleborough CA; Merritt A; Bassoni DL; Raab WJ; Quinn E; Wehrman TS; Davenport AP; Brown AJ; Green A; Wigglesworth MJ; Rees S
J Biomol Screen; 2013 Jun; 18(5):599-609. PubMed ID: 23396314
[TBL] [Abstract][Full Text] [Related]
30. Noncanonical GPCR signaling arising from a PTH receptor-arrestin-Gβγ complex.
Wehbi VL; Stevenson HP; Feinstein TN; Calero G; Romero G; Vilardaga JP
Proc Natl Acad Sci U S A; 2013 Jan; 110(4):1530-5. PubMed ID: 23297229
[TBL] [Abstract][Full Text] [Related]
31. In vivo veritas, the next frontier for functionally selective GPCR ligands.
Beaulieu JM
Methods; 2016 Jan; 92():64-71. PubMed ID: 26320830
[TBL] [Abstract][Full Text] [Related]
32. Identification of key phosphorylation sites in PTH1R that determine arrestin3 binding and fine-tune receptor signaling.
Zindel D; Engel S; Bottrill AR; Pin JP; Prézeau L; Tobin AB; Bünemann M; Krasel C; Butcher AJ
Biochem J; 2016 Nov; 473(22):4173-4192. PubMed ID: 27623777
[TBL] [Abstract][Full Text] [Related]
33. Proline-rich motifs in the parathyroid hormone (PTH)/PTH-related protein receptor C terminus mediate scaffolding of c-Src with beta-arrestin2 for ERK1/2 activation.
Rey A; Manen D; Rizzoli R; Caverzasio J; Ferrari SL
J Biol Chem; 2006 Dec; 281(50):38181-8. PubMed ID: 17038311
[TBL] [Abstract][Full Text] [Related]
34. Extracellular nucleotides enhance agonist potency at the parathyroid hormone 1 receptor.
Kim BH; Pereverzev A; Zhu S; Tong AOM; Dixon SJ; Chidiac P
Cell Signal; 2018 Jun; 46():103-112. PubMed ID: 29501726
[TBL] [Abstract][Full Text] [Related]
35. Actions of Parathyroid Hormone Ligand Analogues in Humanized PTH1R Knockin Mice.
Daley EJ; Yoon SH; Reyes M; Bruce M; Brooks DJ; Bouxsein M; Potts JT; Kronenberg HM; Wein MN; Lanske B; Jüppner H; Gardella TJ
Endocrinology; 2022 Jul; 163(7):. PubMed ID: 35460406
[TBL] [Abstract][Full Text] [Related]
36. Agonist-selective signaling of G protein-coupled receptor: mechanisms and implications.
Zheng H; Loh HH; Law PY
IUBMB Life; 2010 Feb; 62(2):112-9. PubMed ID: 20058265
[TBL] [Abstract][Full Text] [Related]
37. Human PTH-(7-84) inhibits bone resorption in vitro via actions independent of the type 1 PTH/PTHrP receptor.
Divieti P; John MR; Jüppner H; Bringhurst FR
Endocrinology; 2002 Jan; 143(1):171-6. PubMed ID: 11751606
[TBL] [Abstract][Full Text] [Related]
38. 'Biasing' the parathyroid hormone receptor: a novel anabolic approach to increasing bone mass?
Gesty-Palmer D; Luttrell LM
Br J Pharmacol; 2011 Sep; 164(1):59-67. PubMed ID: 21506957
[TBL] [Abstract][Full Text] [Related]
39. Heptahelical terpsichory. Who calls the tune?
Gesty-Palmer D; Luttrell LM
J Recept Signal Transduct Res; 2008; 28(1-2):39-58. PubMed ID: 18437629
[TBL] [Abstract][Full Text] [Related]
40. Elucidating structural and molecular mechanisms of β-arrestin-biased agonism at GPCRs via MS-based proteomics.
Xiao K; Sun J
Cell Signal; 2018 Jan; 41():56-64. PubMed ID: 28939107
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
